Canada’s Intellectual Property Firm

Regulatory disputes for therapeutic products, innovative drugs, controlled drugs and substances, competitor claims

Multinational pharmaceutical and device clients in disputes or interactions with regulators, including how therapeutic products are classified (including from a controlled drugs and substances perspective), competitor claims, and whether a substance is considered an innovative drug